Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.

MLA

Ferguson, Mark S., et al. “Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 28, no. 5, May 2020, pp. 1263–75. EBSCOhost, https://doi.org/10.1016/j.ymthe.2020.02.017.

APA

Ferguson, M. S., Chard Dunmall, L. S., Gangeswaran, R., Marelli, G., Tysome, J. R., Burns, E., Whitehead, M. A., Aksoy, E., Alusi, G., Hiley, C., Ahmed, J., Vanhaesebroeck, B., Lemoine, N. R., & Wang, Y. (2020). Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus. Molecular Therapy : The Journal of the American Society of Gene Therapy, 28(5), 1263–1275. https://doi.org/10.1016/j.ymthe.2020.02.017

Chicago

Ferguson, Mark S, Louisa S Chard Dunmall, Rathi Gangeswaran, Giulia Marelli, James R Tysome, Emily Burns, Maria A Whitehead, et al. 2020. “Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.” Molecular Therapy : The Journal of the American Society of Gene Therapy 28 (5): 1263–75. doi:10.1016/j.ymthe.2020.02.017.